FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4377030849> ?p ?o ?g. }

• W4377030849 endingPage "110064" @default.
• W4377030849 startingPage "110064" @default.
• W4377030849 abstract "Injectable male hormonal contraceptives are effective for preventing pregnancy in clinical trials; however, users may prefer to avoid medical appointments and injections. A self-administered transdermal contraceptive gel may be more acceptable for long-term contraception. Transdermal testosterone gels are widely used to treat hypogonadism and transdermal administration may have utility for male contraception; however, no efficacy data from transdermal male hormonal contraceptive gel are available. We designed and are currently conducting an international, multicenter, open-label study of self-administration of a daily combined testosterone and segesterone acetate (Nestorone) gel for male contraception. The transdermal approach to male contraception raises novel considerations regarding adherence with the daily gel, as well as concern about the potential transfer of the gel and the contraceptive hormones to the female partner. Enrolled couples are in committed relationships. Male partners have baseline normal spermatogenesis and are in good health; female partners are regularly menstruating and at risk for unintended pregnancy. The study’s primary outcome is the rate of pregnancy in couples during the study’s 52-week efficacy phase. Secondary endpoints include the proportion of male participants suppressing sperm production and entering the efficacy phase, side effects, hormone concentrations in male participants and their female partners, sexual function, and regimen acceptability. Enrollment concluded on November 1, 2022, with 462 couples and enrollment is now closed. This report outlines the strategy and design of the first study to examine the contraceptive efficacy of a self-administered male hormonal contraceptive gel. The results will be presented in future reports. Implications The development of a safe, effective, reversible male contraceptive would improve contraceptive options and may decrease rates of unintended pregnancy. This manuscript outlines the study design and analysis plan for an ongoing large international trial of a novel transdermal hormone gel for male contraception. Successful completion of this and future studies of this formulation may lead to the approval of a male contraceptive." @default.
• W4377030849 created "2023-05-19" @default.
• W4377030849 creator A5008434600 @default.
• W4377030849 creator A5012602847 @default.
• W4377030849 creator A5017240945 @default.
• W4377030849 creator A5025254357 @default.
• W4377030849 creator A5029568279 @default.
• W4377030849 creator A5034016429 @default.
• W4377030849 creator A5051950292 @default.
• W4377030849 creator A5072037505 @default.
• W4377030849 creator A5074187805 @default.
• W4377030849 creator A5075943191 @default.
• W4377030849 creator A5078246959 @default.
• W4377030849 creator A5089208409 @default.
• W4377030849 creator A5090807122 @default.
• W4377030849 date "2023-08-01" @default.
• W4377030849 modified "2023-09-30" @default.
• W4377030849 title "Design of an international male contraceptive efficacy trial using a self-administered daily transdermal gel containing testosterone and segesterone acetate (Nestorone)" @default.
• W4377030849 cites W1524852980 @default.
• W4377030849 cites W2001266752 @default.
• W4377030849 cites W2004474660 @default.
• W4377030849 cites W2037394917 @default.
• W4377030849 cites W2038858525 @default.
• W4377030849 cites W2060470126 @default.
• W4377030849 cites W2066559052 @default.
• W4377030849 cites W2090474264 @default.
• W4377030849 cites W2106009601 @default.
• W4377030849 cites W2132322340 @default.
• W4377030849 cites W2147863431 @default.
• W4377030849 cites W2167083509 @default.
• W4377030849 cites W2295442039 @default.
• W4377030849 cites W2529700959 @default.
• W4377030849 cites W2539721976 @default.
• W4377030849 cites W2592395378 @default.
• W4377030849 cites W2791298691 @default.
• W4377030849 cites W2904555347 @default.
• W4377030849 cites W2938078193 @default.
• W4377030849 cites W3125670692 @default.
• W4377030849 cites W4200564056 @default.
• W4377030849 cites W4200612021 @default.
• W4377030849 cites W4250222852 @default.
• W4377030849 cites W4293007148 @default.
• W4377030849 doi "https://doi.org/10.1016/j.contraception.2023.110064" @default.
• W4377030849 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37210024" @default.
• W4377030849 hasPublicationYear "2023" @default.
• W4377030849 type Work @default.
• W4377030849 citedByCount "2" @default.
• W4377030849 countsByYear W43770308492023 @default.
• W4377030849 crossrefType "journal-article" @default.
• W4377030849 hasAuthorship W4377030849A5008434600 @default.
• W4377030849 hasAuthorship W4377030849A5012602847 @default.
• W4377030849 hasAuthorship W4377030849A5017240945 @default.
• W4377030849 hasAuthorship W4377030849A5025254357 @default.
• W4377030849 hasAuthorship W4377030849A5029568279 @default.
• W4377030849 hasAuthorship W4377030849A5034016429 @default.
• W4377030849 hasAuthorship W4377030849A5051950292 @default.
• W4377030849 hasAuthorship W4377030849A5072037505 @default.
• W4377030849 hasAuthorship W4377030849A5074187805 @default.
• W4377030849 hasAuthorship W4377030849A5075943191 @default.
• W4377030849 hasAuthorship W4377030849A5078246959 @default.
• W4377030849 hasAuthorship W4377030849A5089208409 @default.
• W4377030849 hasAuthorship W4377030849A5090807122 @default.
• W4377030849 hasConcept C126322002 @default.
• W4377030849 hasConcept C131872663 @default.
• W4377030849 hasConcept C205679159 @default.
• W4377030849 hasConcept C2776172332 @default.
• W4377030849 hasConcept C2779076696 @default.
• W4377030849 hasConcept C2779234561 @default.
• W4377030849 hasConcept C2779279991 @default.
• W4377030849 hasConcept C2780099242 @default.
• W4377030849 hasConcept C2781413609 @default.
• W4377030849 hasConcept C2908647359 @default.
• W4377030849 hasConcept C29456083 @default.
• W4377030849 hasConcept C2986817661 @default.
• W4377030849 hasConcept C54355233 @default.
• W4377030849 hasConcept C71924100 @default.
• W4377030849 hasConcept C86803240 @default.
• W4377030849 hasConcept C98274493 @default.
• W4377030849 hasConcept C99454951 @default.
• W4377030849 hasConceptScore W4377030849C126322002 @default.
• W4377030849 hasConceptScore W4377030849C131872663 @default.
• W4377030849 hasConceptScore W4377030849C205679159 @default.
• W4377030849 hasConceptScore W4377030849C2776172332 @default.
• W4377030849 hasConceptScore W4377030849C2779076696 @default.
• W4377030849 hasConceptScore W4377030849C2779234561 @default.
• W4377030849 hasConceptScore W4377030849C2779279991 @default.
• W4377030849 hasConceptScore W4377030849C2780099242 @default.
• W4377030849 hasConceptScore W4377030849C2781413609 @default.
• W4377030849 hasConceptScore W4377030849C2908647359 @default.
• W4377030849 hasConceptScore W4377030849C29456083 @default.
• W4377030849 hasConceptScore W4377030849C2986817661 @default.
• W4377030849 hasConceptScore W4377030849C54355233 @default.
• W4377030849 hasConceptScore W4377030849C71924100 @default.
• W4377030849 hasConceptScore W4377030849C86803240 @default.
• W4377030849 hasConceptScore W4377030849C98274493 @default.
• W4377030849 hasConceptScore W4377030849C99454951 @default.
• W4377030849 hasFunder F4320308846 @default.
• W4377030849 hasFunder F4320337611 @default.

• next